Comment
Author: Admin | 2025-04-28
Online pharmacy options, which sometimes have better inventory.What does this mean for compounded versions of tirzepatide?With the return to full stock, the FDA has announced that compounded versions of tirzepatide—allowed as alternatives during shortages—are now being phased out. Restrictions on compounding are set to take effect in early 2025, which means that if you were using a compounded version, you need to find an alternative. If you need help navigating these changes, your healthcare provider and resources like Noom Med can help you consider alternatives. Staying proactive can ensure you don’t experience delays in your treatment.Alternatives to Zepbound®If you can’t find Zepbound® or need a different medication, several alternatives are available that work similarly. Here are a few options to consider:Tirzepatide-based alternativesTirzepatide is the active ingredient in Zepbound® and Mounaro®. In fact, Zepbound and Mounjaro work the same and are prescribed in the same doses; they just have different approved uses. Mounjaro® is FDA-approved for type 2 diabetes but can also be prescribed off-label for weight loss. The list price for Mounjaro® without insurance is $1,086.37 per month.Semaglutide-based alternativesSemaglutide is the active ingredient in the well-known medications Ozempic® and Wegovy®. It’s also the active ingredient in Rybelsus, an oral GLP-1 medication. The biggest difference between semaglutide and tirzepatide is that semaglutide mimics just GLP-1, while tirzepatide medications also mimic GIP. Here’s a look at what these medications are approved for and what they cost:Ozempic® is FDA-approved for type 2 diabetes and is commonly prescribed off-label for weight loss to people
Add Comment